Yang Du
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Nephrology top 10%
Papers in
-
- Epigenetics and DNA Methylation 7
- Circular RNAs in diseases 5
- Cancer-related gene regulation 4
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 4
- Co-authors
- Xiuheng Liu (19 shared papers)Xiaodong Weng (11 shared papers)Lei Wang (10 shared papers)Zhiyuan Chen (5 shared papers)Douglas M. Stocco (1 shared paper)Steven R. King (1 shared paper)Jerome F. Strauss (1 shared paper)Hidemichi Watari (1 shared paper)
- Journals
- Cellular Physiology and Biochemistry (3 papers)Frontiers in Oncology (3 papers)Oxidative Medicine and Cellular Longevity (2 papers)Drug Design Development and Therapy (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Yang Du
36 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 363
- Nephrology 75
- Molecular Biology 765
- Reproductive Medicine 75
- Behavioral Neuroscience 28
Countries citing papers authored by Yang Du
This map shows the geographic impact of Yang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Du more than expected).
Fields of papers citing papers by Yang Du
This network shows the impact of papers produced by Yang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Du. The network helps show where Yang Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 311 | |
| 2 | 2019 | 197 | |
| 3 | 2017 | 74 | |
| 4 | 2017 | 72 | |
| 5 | 2022 | 55 | |
| 6 | 2018 | 50 | |
| 7 | 2022 | 48 | |
| 8 | 2019 | 39 | |
| 9 | 2018 | 37 | |
| 10 | 2021 | 36 | |
| 11 | 2022 | 36 | |
| 12 | 2018 | 36 | |
| 13 | 2017 | 33 | |
| 14 | 2021 | 30 | |
| 15 | 2018 | 29 | |
| 16 | 2021 | 28 | |
| 17 | 2019 | 27 | |
| 18 | miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer. | 2018 | 23 |
| 19 | 1999 | 22 | |
| 20 | 2021 | 22 |
About Yang Du
Yang Du is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Pharmacology and Epidemiology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Epigenetics and DNA Methylation (7 papers), Circular RNAs in diseases (5 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related gene regulation (4 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (363 citations), Nephrology (75 citations), Molecular Biology (765 citations), Reproductive Medicine (75 citations) and Behavioral Neuroscience (28 citations). Yang Du has collaborated with scholars based in China and United States. Frequent co-authors include Xiuheng Liu, Xiaodong Weng, Lei Wang, Zhiyuan Chen, Douglas M. Stocco, Steven R. King, Jerome F. Strauss, Hidemichi Watari, Futoshi Arakane and Caleb B. Kallen. Their work appears in journals such as Cellular Physiology and Biochemistry, Frontiers in Oncology, Oxidative Medicine and Cellular Longevity, Drug Design Development and Therapy and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.